Published in Vaccine Weekly, December 10th, 2003
This brings to five the number of countries where this vaccine candidate currently is in trials.
In South Africa, HIVA.MVA is the second preventive AIDS vaccine candidate to begin a trial in the country this month. The trial of HIVA.MVA is being conducted at the Chris Hani Baragwanath Hospital in Soweto and the Medical Research Council in Durban. AIDS vaccine research in South Africa is coordinated by the South African AIDS Vaccine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly